Author/Editor		Buturović-Ponikvar, Jadranka
Title		Renal replacement therapy in Slovenia: annual report 2001
Type		članek
Source		Nephrol Dial Transplant
Vol. and No.		Letnik 18, št. Suppl 5
Publication year		2003
Volume		str. v53-5
Language		eng
Abstract		The total number of end-stage renal failure patients treated by renal replacement therapy increased, from 1435 at 31 December 2000 to 1542 at 31 December 2001 (7.5% increase). At the end of 2001, 771 p.m.p. end-stage renal failure patients were treated by renal replacement therapy in Slovenia, 73% of them with haemodialysis, 7.4% with peritoneal dialysis and 19.7% had a functioning graft. Incident (new) patients in 2001 were 144 p.m.p. The number of haemodialysis patients increased by 7% compared with the year before, the number of patients on peritoneal dialysis decreased by 3.4% and the number of patients with a functioning graft increased by 13.9%. The gross mortality rate of dialysis patients was stable between the years and was 10.4% in 2001. Erythropoietin therapy was prescribed to 87.3% of dialysis patients (88.9% of haemodialysis patients and 71.7% of patients on peritoneal dialysis). The number of dialysis patients positive for hepatitis B or hepatitis C virus is relatively low, 3.2% of all dialysis patients; an increased number of MRSA-positive dialysis patients is observed in 2001 (2.9% of all dialysis patients). The epidemiology of renal replacement therapy in Slovenia is in general comparable with that of the countries of the European Union.
Descriptors		KIDNEY FAILURE, CHRONIC HEMODIALYSIS RENAL REPLACEMENT THERAPY KIDNEY TRANSPLANTATION ERYTHROPOIETIN PREVALENCE HEMODIALYSIS UNITS, HOSPITAL SLOVENIA